Description:
Applications:
Suitable for use in ELISA. Other applications not tested.
Recommended Dilutions:
ELISA: 5ug/ml
Optimal dilutions to be determined by the researcher.
Hybridoma:
Spleen cells from immunized LOU/c rats were fused with cells of the rat IR983F myeloma cell line.
Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
|
| Type | Isotype | Clone | Grade |
|---|
| Mab | IgG1 | 3H2320 | Affinity Purified |
|
| Size | | Storage | Shipping | Source | Host |
|---|
| 500ug | | -20°C | Blue Ice | Mouse | Rat |
|
| Concentration: |
| ~1mg/ml |
| Immunogen: |
| Mouse IgG1 |
| Purity: |
| Purified by affinity chromatography. |
| Form |
| Supplied as a liquid in PBS, pH 7.2, 0.1% sodium azide, 50% glycerol. Labeled with Biotin. |
| Specificity: |
| Recognizes the heavy chain of mouse IgG1. |
|
| Intended for research use only. Not for use in human, therapeutic, or diagnostic applications. |
1. Song, J. et al. (2000) Heterogeneous distribution of isoactins in cultured vascular smooth muscle cells does not reflect segregation of contractile and cytoskeletal domains. J. Histochem. Cytochem. 48 (11): 1441 - 1452. 2. Denis, O. et al. (1993) Resting B cells can act as antigen presenting cells in vivo and induce antibody responses. Int. Immunol. 5: 71-8. 3. Nakanishi, S. et al. (2010) Sequence analysis of a bacteriocinogenic plasmid of Clostridium butyricum and expression of the bacteriocin gene in Escherichia coli. Anaerobe. 16: 253-7. 4. Echeverria, P.C. et al. (2006) Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein. Vaccine. 24: 4102-10. 5. Huang, C.H. et al. (2011) Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J Immunol. 187: 462-71.
|
|
